Irreproducibility in Preclinical Biomedical Research: Perceptions, Uncertainties, and Knowledge Gaps

Trends in Pharmacological Sciences
Michael F Jarvis, Michael Williams

Abstract

Concerns regarding the reliability of biomedical research outcomes were precipitated by two independent reports from the pharmaceutical industry that documented a lack of reproducibility in preclinical research in the areas of oncology, endocrinology, and hematology. Given their potential impact on public health, these concerns have been extensively covered in the media. Assessing the magnitude and scope of irreproducibility is limited by the anecdotal nature of the initial reports and a lack of quantitative data on specific failures to reproduce published research. Nevertheless, remediation activities have focused on needed enhancements in transparency and consistency in the reporting of experimental methodologies and results. While such initiatives can effectively bridge knowledge gaps and facilitate best practices across established and emerging research disciplines and therapeutic areas, concerns remain on how these improve on the historical process of independent replication in validating research findings and their potential to inhibit scientific innovation.

References

Sep 28, 2001·Journal of the American Podiatric Medical Association·D MoherUNKNOWN CONSORT Group (Consolidated Standards of Reporting Trials)
Dec 4, 2002·Nature Reviews. Drug Discovery·Atul Butte
Aug 3, 2005·PLoS Medicine·John P A Ioannidis
Oct 20, 1989·Science·R S Nicholson
Jul 24, 2010·British Journal of Pharmacology·J C McGrathC L Wainwright
Sep 30, 2010·Infection and Immunity·Arturo Casadevall, Ferric C Fang
Sep 6, 2011·Nature Reviews. Drug Discovery·Florian PrinzKhusru Asadullah
Mar 10, 2012·Frontiers in Computational Neuroscience·Joshua K Hartshorne, Adena Schachner
Oct 3, 2012·Proceedings of the National Academy of Sciences of the United States of America·Ferric C FangArturo Casadevall
May 10, 2013·Translational Stroke Research·Paul A LapchakLinda J Noble-Haeusslein
Jun 12, 2013·Biochemical Pharmacology·Michael J Marino
Jun 15, 2013·Science·Marc Kirschner
Jul 19, 2013·PloS One·R Grant SteenFerric C Fang
Aug 21, 2013·Biochemical Pharmacology·Paul McGonigle, Bruce Ruggeri
Oct 5, 2013·Science·John Bohannon
Nov 20, 2013·Proceedings of the National Academy of Sciences of the United States of America·Kathleen M KokolusElizabeth A Repasky
Nov 23, 2013·Science·Jennifer Couzin-Frankel
Nov 30, 2013·Science·Mara Hvistendahl
Jan 11, 2014·Nature Biotechnology·Michael HayJesse Rosenthal
Feb 1, 2014·Nature·Francis S Collins, Lawrence A Tabak
Feb 14, 2014·Nature·Regina Nuzzo
Mar 29, 2014·Circulation Research·Garret A FitzGerald
Mar 29, 2014·Nature·Steve Perrin
Jul 2, 2014·Environmental Health Perspectives·Kristina A ThayerLinda S Birnbaum
Jul 19, 2014·Cancer Research·Leonard P Freedman, James Inglese
Nov 11, 2014·Science·Marcia McNutt
Dec 2, 2014·Nature Reviews. Drug Discovery·Elie Dolgin
Jan 2, 2015·Circulation Research·C Glenn Begley, John P A Ioannidis
Jan 13, 2015·Journal of Microbiology & Biology Education·Adam Marcus, Ivan Oransky
Feb 12, 2015·Clinical Pharmacology and Therapeutics·L P Freedman, M C Gibson
Feb 27, 2015·Nature Methods·Lewis G HalseyGordon B Drummond
Feb 28, 2015·Science·Jill Neimark
Mar 3, 2015·Annals of the New York Academy of Sciences·Joseph M Furman, Carey D Balaban
Apr 2, 2015·Nature Reviews. Drug Discovery·Jayme L DahlinMichael A Walters
Jun 10, 2015·PLoS Biology·Leonard P FreedmanTimothy S Simcoe
Jun 11, 2015·PloS One·Vincent LarivièrePhilippe Mongeon

❮ Previous
Next ❯

Citations

May 24, 2016·Trends in Pharmacological Sciences·Bernhard Voelkl, Hanno Würbel
Nov 4, 2016·Drug Development Research·Chris R Triggle, David J Triggle
Feb 5, 2019·GigaScience·Mark N WassMartin Michaelis
May 31, 2019·Journal of Neuroscience Research·David H MalinWilliam R Buras
Apr 30, 2020·Pharmacology Research & Perspectives·Andrew J Lawrence, Michael F Jarvis
May 24, 2019·PloS One·Dean A FergussonUNKNOWN Canadian Perioperative Anesthesia Clinical Trials Group
May 24, 2020·Genes, Brain, and Behavior·Patricia KabitzkeDaniela Brunner
Jul 30, 2020·Animals : an Open Access Journal From MDPI·Gilbert ProulxSandra E Baker
Nov 27, 2019·Pharmacology Research & Perspectives·Michael J Parnham, Gerd Geisslinger
Oct 21, 2016·Alcoholism, Clinical and Experimental Research·John C Crabbe
Mar 18, 2017·Current Protocols in Pharmacology·Daniel J Holder, Michael J Marino
Dec 31, 2019·The Journal of Pharmacology and Experimental Therapeutics·Martin C MichelHarvey J Motulsky
Apr 27, 2017·ILAR Journal·Caroline J Zeiss
May 3, 2019·PLoS Biology·Christopher Allen, David M A Mehler
Dec 29, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Martin C MichelHarvey J Motulsky
Jun 4, 2020·Nature Reviews. Neuroscience·Bernhard VoelklHanno Würbel
Aug 11, 2017·European Journal of Clinical Investigation·Stephen Bustin, Tania Nolan
Dec 2, 2020·Nature Communications·Xing-Xing ShenAntonis Rokas
Jul 6, 2019·Molecular Therapy Oncolytics·Dean A FergussonManoj M Lalu
May 30, 2021·BMC Medical Ethics·Daniel Pizzolato, Kris Dierickx
May 18, 2021·Royal Society Open Science·Sabine HoffmannAnne-Laure Boulesteix

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nature Reviews. Clinical Oncology
Eric E Gardner, Charles M Rudin
The Journal of the Royal College of Physicians of Edinburgh
R M Bracewell
© 2022 Meta ULC. All rights reserved